In vitro inhibition of Plasmodium falciparum rosette formation by curdlan sulfate

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 4, 2007, Pages 1321-1326

  Kyriacou, Helen M ^a   Steen, Katie E ^a   Raza, Ahmed ^a   Arman, Monica ^a   Warimwe, George ^b   Bull, Peter C ^b   Havlik, Ivan ^c   Rowe, J Alexandra ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CURDLAN; HEPARIN;

ANTIMALARIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; ERYTHROCYTE; IN VITRO STUDY; MALARIA; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; ROSETTE FORMATION;

ANIMALS; BETA-GLUCANS; HEMAGGLUTINATION TESTS; HUMANS; IMMUNE SERA; PLASMODIUM FALCIPARUM; ROSETTE FORMATION;

EID: 34247105254     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01216-06     Document Type: Article

References (19)

1. Carlson, J., H. P. Ekre, H. Helmby, J. Gysin, B. M. Greenwood, and M. Wahlgren. 1992. Disruption of Plasmodium falciparum erythrocyte rosettes by standard heparin and heparin devoid of anticoagulant activity. Am. J. Trop. Med. Hyg. 46:595-602.
2. Carlson, J., H. Helmby, A. V. Hill, D. Brewster, B. M. Greenwood, and M. Wahlgren. 1990. Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet 336:1457-1460.
3. Evans, S. G., D. Morrison, Y. Kaneko, and I. Havlik. 1998. The effect of curdlan sulphate on development in vitro of Plasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg. 92:87-89.
4. Gordon, M., M. Guralnik, Y. Kaneko, T. Mimura, J. Goodgame, and W. Lang. 1995. Further clinical studies of curdlan sulfate (CRDS)-an anti-HIV agent. J. Med. 26:97-131.
5. Havlik, I., S. Looareesuwan, S. Vannaphan, P. Wilairatana, S. Krudsood, P. E. Thuma, D. Kozbor, N. Watanabe, and Y. Kaneko. 2005. Curdlan sulphate in human severe/cerebral Plasmodium falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 99:333-340.
6. Havlik, I., S. Rovelli, and Y. Kaneko. 1994. The effect of curdlan sulphate on in vitro growth of Plasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg. 88:686-687.
7. Kaneko, Y., O. Yoshida, R. Nakagawa, T. Yoshida, M. Date, S. Ogihara, S. Shioya, Y. Matsuzawa, N. Nagashima, Y. Irie, et al. 1990. Inhibition of HIV-1 infectivity with curdlan sulfate in vitro. Biochem. Pharmacol. 39:793-797.
8. Kaul, D. K., E. F. J. Roth, R. L. Nagel, R. J. Howard, and S. M. Handunnetti. 1991. Resetting of Plasmodium falciparum-infected red blood cells with uninfected red blood cells enhances microvascular obstruction under flow conditions. Blood 78:812-819.
9. Kinyanjui, S. M., T. Howard, T. N. Williams, P. C. Bull, C. I. Newbold, and K. Marsh. 2004. The use of cryopreserved mature trophozoites in assessing antibody recognition of variant surface antigens of Plasmodium falciparum-infected erythrocytes. J. Immunol. Methods 288:9-18.
10. Masihi, K. N., K. Madaj, H. Hintelmann, G. Gast, and Y. Kaneko. 1997. Down-regulation of tumor necrosis factor-alpha, moderate reduction of interleukin-1beta, but not interleukin-6 or interleukin-10, by glucan immunomodulators curdlan sulfate and lentinan. Int. J. Immunopharmacol. 19:463-468.
11. Pain, A., D. J. Ferguson, O. Kai, B. C. Urban, B. Lowe, K. Marsh, and D. J. Roberts. 2001. Platelet-mediated clumping of Plasmodium falciparum-infected erythrocytes is a common adhesive phenotype and is associated with severe malaria. Proc. Natl. Acad. Sci. USA 98:1805-1810.
12. Rowe, A., A. R. Berendt, K. Marsh, and C. I. Newbold. 1994. Plasmodium falciparum: a family of sulphated glycoconjugates disrupts erythrocyte rosettes. Exp. Parasitol. 79:506-516.
13. Rowe, A., J. Obeiro, C. I. Newbold, and K. Marsh. 1995. Plasmodium falciparum rosetting is associated with malaria severity in Kenya. Infect. Immun. 63:2323-2326.
14. Rowe, J. A. 2005. Rosetting, p. 416-426. In I. W. Sherman (ed.), Molecular approaches to malaria. ASM Press, Washington, DC.
15. Rowe, J. A., J. M. Moulds, C. I. Newbold, and L. H. Miller. 1997. P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature 388:292-295.
16. Rowe, J. A., J. Obiero, K. Marsh, and A. Raza. 2002. Positive correlation between rosetting and parasitemia in Plasmodium falciparum clinical isolates. Am. J. Trop. Med. Hyg. 66:458-460.
17. Rowe, J. A., J. Shafi, O. K. Kai, K. Marsh, and A. Raza. 2002. Nonimmune IgM, but not IgG binds to the surface of Plasmodium falciparum-infected erythrocytes and correlates with rosetting and severe malaria. Am. J. Trop. Med. Hyg. 66:692-699.
18. Vogt, A. M., F. Pettersson, K. Moll, C. Jonsson, J. Normark, U. Ribacke, T. G. Egwang, H. P. Ekre, D. Spillmann, Q. Chen, and M. Wahlgren. 2006. Release of sequestered malaria parasites upon injection of a glycosaminoglycan. PLOS Pathog. 2:e100.
19. WHO. 2000. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans. R. Soc. Trop. Med. Hyg. 94(Suppl. 1): S1-S90.